We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $544M
1-Year Est. Return 72.49%
This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+72.49%
3 Year Est. Return
+451.42%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$392M
AUM Growth
+$17.6M
Cap. Flow
+$3.68M
Cap. Flow %
0.94%
Top 10 Hldgs %
60.17%
Holding
139
New
22
Increased
37
Reduced
35
Closed
10

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$7.69M
2
ALXO icon
ALX Oncology
ALXO
+$4.88M
3
AMD icon
Advanced Micro Devices
AMD
+$4.75M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$1.56M
5
ASTSW
AST SpaceMobile, Inc. Warrant
ASTSW
+$1.51M

Top Sells

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$6.02M
2
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$5.35M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.37M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$3.3M
5
MRNA icon
Moderna
MRNA
+$2.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.59%
2 Healthcare 24.36%
3 Technology 24.32%
4 Communication Services 14.32%
5 Miscellaneous 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPNG icon
26
Coupang
CPNG
$29.7B
$4.24M 1.08%
201,900
+5,000
+3% +$108K
ZLAB icon
27
Zai Lab
ZLAB
$2.93B
$3.75M 0.96%
215,789
-24,894
-10% -$438K
ASTSW
28
DELISTED
AST SpaceMobile, Inc. Warrant
ASTSW
$3.71M 0.95%
+1,034,275
New +$1.51M
MRNA icon
29
Moderna
MRNA
$55.1B
$2.72M 0.69%
23,261
-16,600
-42% -$2.1M
QURE icon
30
uniQure
QURE
$3.38B
$2.57M 0.66%
640,416
+61,501
+11% +$299K
ACAD icon
31
Acadia Pharmaceuticals
ACAD
$5.02B
$2.35M 0.6%
148,400
– –
ALXO icon
32
ALX Oncology
ALXO
$277M
$2.27M 0.58%
+396,966
New +$4.88M
HEI.A icon
33
HEICO Corp Class A
HEI.A
$34.9B
$2.11M 0.54%
11,865
– –
GRND.WS
34
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$2.03M 0.52%
701,118
+98,788
+16% +$220K
CLBTW
35
DELISTED
Cellebrite DI Ltd. Warrants
CLBTW
$1.81M 0.46%
643,948
-5,479
-0.8% -$12.9K
SMR.WS
36
DELISTED
NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SMR.WS
$1.71M 0.43%
690,449
+243,476
+54% +$316K
BIIB icon
37
Biogen
BIIB
$32.3B
$1.6M 0.41%
7,000
-160
-2% -$34.8K
UAA icon
38
Under Armour
UAA
$2.18B
$1.46M 0.37%
226,200
+3,300
+1% +$22.5K
CRSP icon
39
CRISPR Therapeutics
CRSP
$5.58B
$1.45M 0.37%
27,347
+14,600
+115% +$845K
ABEV icon
40
Ambev
ABEV
$44.1B
$1.31M 0.33%
635,914
+176,672
+38% +$402K
KRYS icon
41
Krystal Biotech
KRYS
$10.4B
$1.14M 0.29%
6,420
+1,920
+43% +$322K
BF.B icon
42
Brown-Forman Class B
BF.B
$12.5B
$1.1M 0.28%
25,800
– –
PFE icon
43
Pfizer
PFE
$159B
$1.01M 0.26%
36,120
+6,960
+24% +$192K
FOX icon
44
Fox Class B
FOX
$25.8B
$998K 0.25%
30,900
– –
IMTXW
45
DELISTED
Immatics N.V. Warrants
IMTXW
$902K 0.23%
295,814
+45,231
+18% +$127K
RNAM
46
DELISTED
Avidity Biosciences
RNAM
$863K 0.22%
22,242
+14,200
+177% +$407K
FDMT icon
47
4D Molecular Therapeutics
FDMT
$810M
$823K 0.21%
40,000
+9,000
+29% +$226K
C icon
48
Citigroup
C
$223B
$807K 0.21%
12,478
-2,100
-14% -$129K
MGTX icon
49
MeiraGTx Holdings
MGTX
$1.33B
$804K 0.21%
203,960
+83,975
+70% +$424K
NOV icon
50
NOV
NOV
$7.48B
$734K 0.19%
39,719
-4,900
-11% -$91.8K
1
2
3 4 5

Similar funds

RWMH
Riverpoint Wealth Management Holdings Chicago, Illinois $544M AUM 20.39% 1-Year Est. Return
BPIA
Broad Peak Investment Advisers Singapore $544M AUM 132.56% 1-Year Est. Return
AFA
Abacus FCF Advisors Orlando, Florida $544M AUM 70.51% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $544M AUM 40.38% 1-Year Est. Return
FIM
FWL Investment Management Dallas, Texas $545M AUM 64.06% 1-Year Est. Return
DKAM
Drummond Knight Asset Management Crows Nest, NSW, Australia $545M AUM 73.62% 1-Year Est. Return
CCM
Coerente Capital Management Toronto, Ontario, Canada $543M AUM 7.53% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Privium Fund Management's Q2 2024 Portfolio in Review

As of Q2 2024, Privium Fund Management held 139 positions worth $392M, up 4.7% from $374M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Privium Fund Management's Q2 2024 filing shows 22 new, 37 increased, 35 reduced and 10 closed positions. Its largest new stake was ALX Oncology: 396,966 shares worth $2.27M. The largest sale was Spotify, an estimated $6.02M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

  • Privium Fund Management's largest Q2 2024 buy was ALX Oncology: 396,966 shares worth $2.27M.
  • Privium Fund Management added most to Tesla in Q2 2024, an estimated $7.69M increase.
  • Privium Fund Management's biggest Q2 2024 reduction was Spotify, cutting an estimated $6.02M.
  • Privium Fund Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $5.35M.
  • Privium Fund Management's ten largest holdings make up 60% of its $392M portfolio in Q2 2024.
  • Privium Fund Management opened 22 new positions and closed 10 in Q2 2024.
  • Privium Fund Management's portfolio value rose 4.7% quarter-over-quarter to $392M.

Based on Privium Fund Management's 13F filing for Q2 2024, filed 1 Aug 2024.